OTC to Big Board: drawbacks

Listing your company's stock on the Big Board is like the old saw about buying an IBM computer: Nobody gets fired for doing it. But you could be sacrificing liquidity (the ability to market a stock quickly without sacrificing much in price), say Texas A&M Profs. David A. Dubofsky and John C. Groth in the winter issue of The Journal of Financial Research of Georgetown University.

They looked at 344 switches between 1975 and '81. The findings: There was ''A sharp and apparently permanent decline in liquidity'' for securities switching from over-the-counter market to the New York Stock Exchange; companies switching from the American Stock Exchange to the NYSE ''realize an increase in liquidity after the switch date, followed by a gradual decline'' to slightly above pre-switch levels; liquidity after switching from OTC to AMEX ''declined by 24.6 percent.'' Greater liquidity is often a factor cited for moving one's stock listing from the over-the-counter market to the New York Stock Exchange or the American Exchange.

But competing dealers in OTC securities, the professors say, ''may provide more continuous liquid markets than the organized exchanges that employ monopolist specialists.

About these ads
Sponsored Content by LockerDome

We want to hear, did we miss an angle we should have covered? Should we come back to this topic? Or just give us a rating for this story. We want to hear from you.

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK